Department of Health and Human Services July 7, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 4 of 4
2005 White House Conference on Aging Policy Committee
Pursuant to Section 10(a) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2), notice is hereby given that the Policy Committee for the 2005 White House Conference on Aging (WHCoA) voted to change the date of the WHCoA event from October 23 to 26, 2005 to December 11 to 14, 2005. The 2005 WHCoA will be held at the Marriott Wardman Park Hotel, 2660 Woodley Road, NW., Washington, DC 20008.
Memorandum of Understanding Between the U.S. Food and Drug Administration and the State of South Carolina, Department of Health and Environmental Control, Bureau of Radiological Health
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the State of South Carolina, Department of Health and Environmental Control, Bureau of Radiological Health. The purpose is to authorize the State of South Carolina, through the South Carolina Department of Health and Environmental Control (DHEC), to conduct a State as certifiers program in South Carolina under the Mammography Quality Standards Act (MQSA) as amended by the Mammography Quality Standards Reauthorization Act of 1998 (MQSRA).
Memorandum of Understanding Between the U.S. Food and Drug Administration and Howard University, Washington, DC
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the U.S. Food and Drug Administration and Howard University, Washington, DC. The purpose is to implement an integrated system of shared interest in scientific progress through an exchange of scientific capital in the diverse fields of science that directly and indirectly affect human and animal health and medicine.
Memorandum of Understanding Between the Food and Drug Administration and the University of Houston
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and the University of Houston (UH). The purpose of the MOU is to implement an integrated system of shared interest in scientific progress through an exchange of scientific capital, in the diverse fields of science that directly, and indirectly affect human and animal health and medicine.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
